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a  b  s  t  r  a  c  t
RNA  interference  has  provided  valuable  insight  into  a wide  range  of  biological  systems  and  is a powerful
tool  for  the  analysis  of gene  function.  The  exploitation  of this  pathway  to block  the expression  of  speciﬁc
gene  targets  holds  considerable  promise  for the development  of novel  RNAi-based  insect  management
strategies.  In addition,  there  are  a wide  number  of  future  potential  applications  of RNAi  to control  agri-
cultural  insect  pests  as  well  as  its use  for prevention  of  diseases  in  beneﬁcial  insects.  The potential  to
synthesise  large  quantities  of dsRNA  by  in-vitro  transcription  or  in  bacterial  systems  for RNA  interference
applications  has  generated  signiﬁcant  demand  for the development  and  application  of  high throughput
analytical  tools  for the  rapid  extraction,  puriﬁcation  and  analysis  of  dsRNA.  Here  we have developed
analytical  methods  that  enable  the rapid  puriﬁcation  of  dsRNA  from  associated  impurities  from  bacterial
cells  in  conjunction  with  downstream  analyses.  We  have  optimised  TRIzol  extractions  in conjunction
with  a single  step  protocol  to  remove  contaminating  DNA  and  ssRNA,  using  RNase  T1/DNase  I  digestion
under  high-salt  conditions  in combination  with  solid  phase  extraction  to purify  the  dsRNA.  In  addition,
we  have  utilised  and  developed  IP RP HPLC  for  the rapid, high  resolution  analysis  of the  dsRNA.  Further-
more,  we  have  optimised  base-speciﬁc  cleavage  of  dsRNA  by  RNase  A  and  developed  a novel  method
utilising  RNase  T1 for RNase  mass  mapping  approaches  to further  characterise  the dsRNA  using  liquid
chromatography  interfaced  with  mass  spectrometry.
©  2017  The  Authors.  Published  by Elsevier  B.V. This  is  an open  access  article  under  the  CC BY  license
(http://creativecommons.org/licenses/by/4.0/).. Introduction
RNA interference (RNAi) is a post-transcriptional inhibition
f gene expression by a homology-dependent mRNA degrada-
ion mechanism evolved in many eukaryotes as a defence barrier
gainst exogenous genetic materials such as transposons and
iral genomes [1,2]. RNAi utilises short, double-stranded (ds)
NAs termed small interfering RNAs (siRNA) to downregulate the
xpression of genes that contain complementary sequences. This
echanism was ﬁrst discovered in Caenorhabditis elegans and sub-
equently in plants [3,4].
The RNAi pathway is initiated by an enzyme called Dicer (a
ember of the RNase III family), which binds and cleaves long
sRNA molecules into short dsRNA fragments (siRNAs) of approx-
∗ Corresponding author.
E-mail address: m.dickman@shefﬁeld.ac.uk (M.J. Dickman).
ttp://dx.doi.org/10.1016/j.chroma.2016.12.062
021-9673/© 2017 The Authors. Published by Elsevier B.V. This is an open access article uimately 20 bp length. One strand of the siRNA duplex binds to
Argonaute (Ago), an RNase H–like protein which represses transla-
tion of an mRNA on the basis of sequence complementarity [5].
In eukaryotes, endogenous siRNA pathways have many roles,
including repressing repetitive and transposable genomic elements
and defending the host against infection by RNA viruses. The
RNAi pathway in insects includes several branches that function
to silence the expression of both endogenous genes of the host and
those of parasite and pathogen invaders. The exploitation of this
pathway to block the expression of speciﬁc gene targets holds con-
siderable promise for the development of novel RNAi-based insect
management strategies [6]. In addition there are a wide number of
future potential applications of RNAi to control agricultural insect
pests as well as its use for prevention of diseases in beneﬁcial insects
[7].The induction of RNAi by exogenous supply of dsRNA has
been successful in a number of different organisms [3,8]. Oral
administration of dsRNA in pest insects has been demonstrated to
nder the CC BY license (http://creativecommons.org/licenses/by/4.0/).
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nduce RNAi and has signiﬁcant potential utility for crop protec-
ion approaches [9,10]. The size of the dsRNA product is also an
mportant issue as short dsRNA have been reported to be limited in
enetrance and expressivity [11]. Initial studies using E. coli BL21
DE3) to generate dsRNA resulted in products that were degraded
y RNase III to short, partially digested dsRNA [12,13]. These short
sRNA molecules of about 12–15 bp in length are incapable of
riggering RNA interference response in mammalian cells [14]. An
Nase III-deﬁcient E. coli strain HT115 (DE3) was  engineered to
roduce intact speciﬁc dsRNA and when fed to C. elegans triggered
trong interference [12].
Synthetic siRNA oligonucleotide duplexes or hairpin RNAs for
NAi studies have also been widely employed. However, a num-
er of caveats are associated with these approaches including the
osts associated with the synthesis of the oligonucleotide (often
equiring speciﬁc modiﬁcations) and the time-consuming proce-
ures including transfection and drug selection that are required
or RNAi. The use of in-vitro transcription or bacteria to generate
iRNAs can potentially reduce the cost of siRNAs and can provide a
eans of delivering siRNAs into cells. Large quantities of long dsR-
As can be produced by in-vitro transcription or in E. coli cells that
ack RNase III with inducible T7 polymerase or 6 RNA dependent
NA polymerase overexpression systems [11,15,16]. More recently,
lternative approaches using a plant viral siRNA binding protein
ave been used to generate and purify siRNAs generated in bacteria
17]. However, for laboratory purposes we found it more practical
o synthesise dsRNA using an inducible T7 polymerase overexpres-
ion system.
A variety of methods have been developed and utilised for
he selective puriﬁcation of dsRNA, including strategies utilising
ecombinant dsRNA-binding protein [18], phenol extraction in con-
unction with cellulose afﬁnity chromatography [19,20] and the
se of differential solubility of nucleic acids in LiCl to extract total
sRNA from viral infested tissues or cells [21]. A method based
n anion exchange chromatography using convective interaction
edia (CIM) monolithic columns has also be used to separate
sRNA from ssRNA [22]. The resulting puriﬁed dsRNA is not read-
ly amenable to conventional or next-generational sequencing
echniques (NGS) or directly compatible with downstream mass
pectrometry analysis. NGS approaches generate only short reads
herefore does not readily provide important quantitative charac-
erisation of large dsRNA.
The development of the analytical platform in this study enables
he efﬁcient and effective puriﬁcation of dsRNA from bacterial cells
rior to downstream RNAi applications. Furthermore, this approach
nables relative quantiﬁcation and characterisation of the dsRNA
roduct providing high throughput analysis of the dsRNA, valida-
ion of the duplex nature of the dsRNA and characterisation of the
sRNA using mass spectrometry in conjunction with RNase mass
apping.
. Materials and methods
.1. Chemicals and reagents
Q5
®
High-Fidelity DNA Polymerase, dNTPs, NTPS, designed
rimers from MWG  Euroﬁns were used for PCR and in vitro
ranscription performed using HiScribeTM T7 High Yield RNA
ynthesis Kit (New England Biolabs) and Synthetic gene from
eneArt
®
Gene Synthesis (Invitrogen Life technologies). The
. coli strain, HT115(DE3) was obtained from Cold Spring
arbor Laboratory, NY, USA. Ampicillin sodium salt (Sigma-
ldrich), Tetracycline hydrochloride (Sigma-Aldrich), Isopropyl
-d-1-thiogalactopyranoside (IPTG) ≥99% (Sigma-Aldrich). TRIzol®
axTM Bacterial RNA Isolation Kit with TRIzol
®
, Max  Bacterialogr. A 1484 (2017) 14–25 15
Enhancement Reagent (Life technologies) and the RibopureTM bac-
terial RNA extraction kit (Life technologies) were used for RNA
extractions. The WAVE System Transgenomic HPLC, Proswift RP-1S
Monolith column (4.6 × 50 mm I.D. ThermoFisher) and buffers pre-
pared with (TEAA) pH 7.0 (Fluka, UK), acetonitrile (ThermoFisher),
HPLC grade water were used for nucleic acid analyses. RNase T1
(Ambion), RNase A (Ambion) and DNase I (Ambion) were used for
puriﬁcation and mass mapping of dsRNA. The Accucore C18 column
(150 mm × 2.1 mm ID), the U3000 HPLC system (Thermo Scientiﬁc),
and maXis Ultra High Resolution Time of Flight Instrument (Bruker
Daltonics) were used in oligonucleotide analyses.
2.2. In vitro transcription of dsRNA
DNA was  ampliﬁed from the plasmid pCOIV that contains a
765 bp sequence ﬂanked on both sides with T7 promoter sequences
and optimised synthetic T7 terminator sequences. PCR was per-
formed using primers ﬂanking the dsRNA gene using the following
conditions. 0.02 U/l  Q5
®
High-Fidelity DNA Polymerase, 200 M
dNTPs, 0.5 M each of forward and reverse primer and 10 ng DNA
template. The following PCR parameters were used: the initial
denaturation was  1 cycle of 30 s at 98 ◦C, 30 cycles of 30 s at
98 ◦C, 30 s at 68 ◦C, and 30 s at 72 ◦C and a ﬁnal extension at 72 ◦C
for 2 mins. dsRNA and ssRNA were also generated using in vitro
transcription in conjunction with HiScribeTM T7 High Yield RNA
Synthesis Kit (New England Biolabs): 10 mM NTPs, 1 x reaction
buffer, 1 g DNA template and 2 L HiScribeTM T7 polymerase in
20 L RNase-free water.
2.3. Expression of dsRNA gene using E. coli HT115(DE3)
The E. coli strain, HT115(DE3) [12] was  obtained from Cold
Spring Harbor Laboratory, NY, USA. E. coli HT115 (DE3) cells were
transformed with pCOIV. A colony from the transformed cells was
inoculated into 5 mL  LB media containing 10 ng/mL tetracycline
and 100 g/mL ampicillin and incubated overnight at 37 ◦C. This
was followed by seeding 2 mL  of the overnight culture into a 50 mL
LB media containing the same concentration of antibiotics, incu-
bated at 37 ◦C and allowed to reach an OD600 nm of 1. Then IPTG
was added to the culture to 1 mM ﬁnal concentration followed by
further incubation at 37 ◦C for 3 h.
2.4. Extraction and puriﬁcation of RNA
The total RNA was extracted from the cells using TRIzol
®
MaxTM
Bacterial RNA Isolation Kit with TRIzol
®
and Max Bacterial Enhance-
ment Reagent (Life technologies) was used to extract total RNA
following the manufacturer’s instructions. Brieﬂy, the cells were
harvested by centrifugation at 4500 rpm at 4 ◦C for 10 min. Approx-
imately 108 E. coli cells were suspended in pre-heated 200 L Max
Bacterial Enhancement Reagent and heated at 95 ◦C for 4 mins. 1 mL
of TRIzol reagent was added, cells thoroughly mixed and incubated
at room temperature for 5 min. Phenol-chloroform phase separa-
tion was achieved by adding 200 L chloroform and incubating for 2
mins followed by centrifugation at 13,000 rpm for 5 min. The aque-
ous phase was transferred to a fresh 2 mL  Eppendorf tube. The total
RNA was precipitated out of solution by adding 1 mL isopropanol,
incubating for 5 min  and centrifuging at 14000 rpm for 7 min. The
total RNA pellet was  washed with 500 L 70% ethanol and then dis-
solved in 100 L distilled water. For puriﬁcation of dsRNA, 4 U of
DNase I (Ambion) was  added and incubated for 10 min  and the solu-
tion was  adjusted to 300 mM NaCl and 3000 U of RNase T1 (Ambion)
was added and incubated at 37 ◦C for 15 min. Then 560 L PB buffer
(Qiagen), 40 L 5 M NaCl and 40 L Isopropanol was added prior
to solid phase extraction using silica-membrane column (Qiagen).
After loading, the column was  centrifuged at 13000 rpm for 1 min.
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he ﬂow through was discarded and 700 L PE (Qiagen) buffer
dded followed by centrifugation at 13,000 rpm for 1 min. The
ow through was discarded and the centrifugation step repeated.
he dsRNA was eluted with 100 L distilled water. It is important
o thoroughly desalt the dsRNA prior to digestions using RNase
1 in the presence of DMSO and heating the dsRNA. In addition,
otal RNA was extracted from cells using the RibopureTM bacterial
NA extraction kit (Life technologies) following the manufacturer’s
nstructions.
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2.5. Ion pair-reverse phase high performance liquid
chromatography (IP-RP HPLC)
All samples were analysed by IP-RP-HPLC on a Transgenomic
HPLC using a Proswift RP-1S Monolith column (4.6 × 50 mm I.D.
ThermoFisher). Chromatograms were analysed using UV detec-
tion at a wavelength of 260 nm.  The chromatographic analysis was
performed using the following conditions: Buffer A 0.1 M triethy-
lammonium acetate (TEAA) pH 7.0 (Fluka, UK); Buffer B 0.1 M TEAA,
15 20
 (minutes)
15 20
ime (minutes)
16S
23S
16S
23S
acterial RNA extraction kit. (a) IP RP HPLC chromatogram of total RNA from E. coli
romatogram of total RNA from E. coli HT115 (DE3) cells transformed with plasmid
ighted. 2 and 8 g of total RNA was analysed using gradient condition 1 at 260 nm
A.O. Nwokeoji et al. / J. Chromatogr. A 1484 (2017) 14–25 17
Retention Time (min)
0 5 10 15 20
-2
0
2
4
6
8
10
12
14
16
16S
23S
dsRNA
Retention Time (min)
0 5 10 15 20
-20
0
20
40
60
80
100
16S
23S
A
B
5 10 15 20
-20
0
20
40
60
80
100
120
140
160
180
200
dsRNA
ssRNA/ degraded RNA
A
bs
or
ba
nc
e 
(m
V
)
Retention time (minutes)
C
A
bs
or
ba
nc
e 
(m
V
)
A
bs
or
ba
nc
e 
(m
V
)
Fig. 2. IP RP HPLC chromatograms of total RNA extracted from E. coli using TRIzol® MaxTM Bacterial RNA Isolation Kit. (a) IP RP HPLC chromatogram of total RNA from E. coli
HT115  (DE3) cells transformed with plasmid pCOIV prior to induction. (b) IP RP HPLC chromatogram of total RNA from E. coli HT115 (DE3) cells transformed with plasmid
pCOIV  following induction with IPTG. The corresponding rRNA and dsRNA are highlighted. Approximately 15 g of total RNA was  analysed using gradient condition 1 at
260  nm UV detection. (c) IP RP HPLC chromatogram of total RNA extracted from E. coli HT115 (DE3) in conjunction with mechanical shearing and TRIzol. Approximately
10  g of total RNA was  analysed using gradient condition 1 at 260 nm UV detection.
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H 7.0 containing 25% acetonitrile (ThermoFisher). RNA was ana-
ysed using the following gradients. Gradient (1) starting at 20%
uffer B the linear gradient was extended to 22% buffer B in 2 min,
ollowed by a linear extension to 52% buffer B over 15 min, followed
y a linear extension to 65% buffer B over 2.5 min  at a ﬂow rate of
.0 mL/min at 50 ◦C and 75 ◦C. Gradient (2) starting at 35% buffer B
he linear gradient was extended to 55% buffer B in 3 min, followed
y a linear extension to 65% buffer B over 10 min, isocratic at 65%
uffer B for 2.5 mins and a linear extension to 100% buffer B over
.5 min  at a ﬂow rate of 1.0 mL/min at both non denaturing (50 ◦C)
nd denaturing conditions (75 ◦C).
.6. Agarose gel electrophoresis
1% agarose gel was used for gel electrophoresis. RNA loading dye
x (NEB) was added to RNA sample and loaded on the gel. 1X TAE
uffer (40 mM Tris (pH 7.6), 20 mM acetic acid and 1 mM EDTA) was
sed to perform electrophoresis at 100 V for 45 min. The agarose
el was pre-stained with ethidium bromide and UV imaging sys-
em ﬁtted with charge coupled device (CCD) camera (Biospectrum
®
ultispectral Imaging System).
.7. Digestion of ssRNA using RNase A/T1 and DNase I
RNase T1 digests was performed using a ratio of 1000 U of RNase
1 to 1 g RNA in RNase-free water or RNase free water + 0.5 M NaCl
or 15 mins at 37 ◦C. The RNase A assay was performed using a ratio
0 ng RNase A per 1 g RNA in RNase-free water for 15 min  at 37 ◦C.
emoval of DNA was performed using 2 U DNase I to 1 g RNA.
.8. RNase mass mapping
Following puriﬁcation, 5 g of dsRNA in RNase-free water was
ncubated with 100 ng RNase A at 37 ◦C for 30 min. For RNase T1
ass mapping, 5 g of puriﬁed dsRNA in 50% DMSO was  incubated
t 90 ◦C for 30 s and allowed to cool to room temp. 2000 U RNase
1 was added and reaction mix  incubated for 15 min  at 37 ◦C.
Subsequently, 2.5 g, was analysed using LC ESI MS  using an
ccucore C18 column (150 mm × 2.1 mm ID). LC MS  buffer A:
0 mM 1,1,1,3,3,3,-Hexaﬂuoro-2-propanol (HFIP, Sigma-Aldrich)
ith 20 mM TEAA (Sigma-Aldrich), LC MS  buffer B: LC MS  buffer
 with 50% acetonitrile (v/v) (ThermoFisher). Starting with 10%
uffer B, an isocratic step was performed for 2 mins followed by
 linear extension to 20% B in 20 mins, then 20%B to 30% B over
0 min  and 30%B to 90%B for 3 mins at a ﬂow rate of 100 L min−1.
ass spectrometry analysis was performed using a maXis Ultra
igh Resolution Time of Flight Instrument (Bruker Daltonics).
Data acquisition was performed in negative ion mode with
 selected mass range of 300−2500 m/z. Ionisation voltage of
 2000 V was used to maintain capillary current between 30
nd 50 nA. Temperature of nitrogen 300 ◦C at a ﬂow rate of
.0 L/h and N2 nebuliser gas pressure at 0.4 bar. A list of theoret-
cal monoisotopic masses of oligoribonucleotides was  generated
sing Mongo Oligo Mass Calculator (http://mods.rna.albany.edu/
asspec/Mongo-Oligo). The output of this analysis produces a the-
retical sequence ladder of oligoribonucleotides for the dsRNA
ith all possible chemical termini including; 5′-OH, −phosphate,
cyclic phosphate and 3′-OH, −phosphate, −cyclic phosphate.
ongo Oligo Mass Calculator was also used to predict the CID frag-
ent ions of the theoretical oligoribonucleotides.ogr. A 1484 (2017) 14–25
3. Results and discussion
3.1. Extraction of dsRNA from E. coli
Common approaches used to extract RNA from bacterial cells
are centred on methods that combine guanidinium thiocyanate
and phenol/chloroform extractions [23]. A variety of methods have
been employed for the extraction of RNA from bacterial cells, how-
ever these methods can often result in low yields or low quality
total RNA [24]. Improvements in the quality and quantity of RNA
extracted from bacterial cells were achieved using hot SDS/hot
phenol isolation techniques. However these approaches required
DNase treatment prior to downstream gene expression analysis
[25]. More recently, alternative approaches using formamide-based
RNA extractions from bacterial cells were developed to efﬁciently
extract total RNA from bacterial cells [26]. This method termed
(RNAsnapTM) generated similar quality and yield compared to the
commercial guanidium isothiocyanate −phenol/chloroform based
methods. In addition phenol/chloroform free methods have also
been developed for the efﬁcient extraction of RNA [27]. Therefore,
optimising efﬁcient extraction of high quality RNA whilst simul-
taneously minimising RNA degradation and rapidly assessing RNA
quality is important.
E. coli HT115 (DE3) cells were transformed with plasmid pCOIV
to express a dsRNA (∼756 bps). Following induction and tran-
scription of the dsRNA in E. coli we  evaluated a number of
alternative commercially available extraction methods including
TRIzol
®
MaxTM Bacterial RNA Isolation Kit (TRIzol
®
reagent) and
the RibopureTM bacterial RNA extraction kit (RNAwiz reagent) to
extract the dsRNA. Following extraction of the dsRNA, analysis was
performed using ion pair reverse phase liquid chromatography
(IP-RP HPLC). The results showed the RiboPureTM RNA Puriﬁca-
tion Kit-bacteria kit efﬁciently extracted high quality ribosomal
RNA/ssRNAs but no dsRNA was observed (see Fig. 1a/b). RNA
extracted from the E. coli cells using TRIzol
®
(TRIzol
®
MaxTM Bac-
terial RNA Isolation Kit) and analysed using IP RP HPLC is shown in
Fig. 2. The results also show that the rRNAs (rRNAs) are efﬁciently
extracted with minimal degradation. In contrast to using RNAwiz,
high yields of dsRNA were also obtained.
For the extraction of dsRNA, optimising the extraction methods
to ensure minimal degradation of the ssRNA (rRNA) is not nec-
essarily a stringent requirement in contrast to downstream gene
expression analysis using qRT PCR or the preparation of RNAseq
libraries. The additional stability conferred by the dsRNA over
ssRNA is advantageous during extraction. An example is shown in
Fig. 2c where using mechanical shearing in conjunction with TRIzol
reagent to extract the dsRNA resulted in rRNA degradation during
the procedure. However, the results show that extraction of the
dsRNA has not been signiﬁcantly affected.
3.2. Puriﬁcation of dsRNA
Following extraction of total RNA from E. coli cells expressing
the dsRNA using the TRIzol
®
reagent, further puriﬁcation meth-
ods were optimised in an effort to remove contaminating RNA
(tRNA/rRNA) and DNA. Current strategies to isolate dsRNA use
phenol-chloroform extractions in conjunction with RNase A/DNase
to remove contaminating ssRNA and DNA [12]. We  have observed
that at very low salt concentrations dsRNA is more resistant to
RNase T1 than to RNase A, (see Fig. 3a). The result suggests that
dsRNA may  be relatively susceptible to RNase A digestion under
low salt concentrations, suggesting that RNase T1 is not only better
suited for the selective degradation of ssRNA species than RNase A
but also for optimal dsRNA quality and yield.
Following extraction of total RNA from E. coli cells expressing
dsRNA using TRIzol
®
reagent extraction in conjunction with gel
A.O. Nwokeoji et al. / J. Chromatogr. A 1484 (2017) 14–25 19
Fig. 3. Puriﬁcation of dsRNA from E. coli. (a) Agarose gel electrophoresis of puriﬁed in vitro transcribed dsRNA and ssRNA. Following in vitro transcription, 2 g of dsRNA
containing excess ssRNA were incubated with RNase T1 in both the presence and absence of 0.5 M NaCl and puriﬁed by SPE. (b) Agarose gel electrophoresis of extracted and
puriﬁed  dsRNA. Following TRIzol extraction of total RNA from E. coli expressing dsRNA samples were incubated with RNase T1 in both the presence and absence of 0.3 M NaCl
as  indicated prior to puriﬁcation using solid phase extraction. Control experiments were performed using total RNA from non-induced E. coli. (c) IP RP HPLC chromatogram
of  puriﬁed dsRNA. Following TRIzol extraction the total RNA from E. coli was puriﬁed in a single step using RNase T1/DNase in conjunction with solid phase extraction prior
to  analysis using IP RP HPLC gradient condition 1 at 260 nm UV detection.
20 A.O. Nwokeoji et al. / J. Chromatogr. A 1484 (2017) 14–25
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Fig. 4. IP RP HPLC analyses of dsRNA and ssRNA under denaturing and non-denaturing conditions. (a) IP RP HPLC chromatogram of dsRNA at 50 ◦C. (b) IP RP HPLC chromatogram
of  dsRNA at 75 ◦C. (c) IP RP HPLC chromatogram of ssRNA at 50 ◦C. (d) IP RP HPLC chromatogram of ssRNA at 75 ◦C. (e) IP RP HPLC chromatogram of in vitro transcribed dsRNA
with  an excess of ssRNA. (f) IP RP HPLC chromatogram of puriﬁed dsRNA. Following in vitro transcription, the RNA was puriﬁed in a single step using RNase T1/DNase in
conjunction with solid phase extraction. 2–3 g of in vitro transcribed ds/ssRNA was analysed using gradient 1 at 260 nm UV detection.
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lectrophoresis analysis, we demonstrated that RNase T1 selec-
ively degrades ssRNA (rRNAs) without degrading the dsRNA in
oth the presence or absence of 0.3 M NaCl (see Fig. 3b) which is
onsistent with previous observations that dsRNA is unaffected by
Nase T1 [28]. Control experiments are shown using total RNA from
on-induced E. coli cells.
Therefore, in an approach to purify the dsRNA from total RNA
xtracted from E. coli and minimise the degradation of dsRNA, an
ptimised method was developed using RNase T1/DNase I treat-
ent in conjunction with solid phase extraction using a silica
embrane spin column to further purify the dsRNA from contami-
ating degraded ssRNA/DNA, salts and phenol/choloroform. Fig. 3c
hows the IP-RP HPLC analysis of the puriﬁed dsRNA from E. coli
ells expressing the dsRNA. The results demonstrate the successful
uriﬁcation of dsRNA from the E. coli cells expressing dsRNA from
ontaminating ssRNA (rRNA/tRNA) and their associated degrada-
ion products.
.3. Ion pair reverse phase HPLC analysis of dsRNA
In order to validate the successful puriﬁcation of the dsRNA
rom E. coli prior to downstream RNAi studies, it is important to
nalyse the dsRNA. A number of important parameters includ-
ng the homogeneity, presence of impurities, validation of dsRNA
vs ssRNA) and sequence of the dsRNA product should be mea-
ured as part of the analytical platform. Ion pair reverse phase
igh-performance liquid chromatography (IP RP HPLC) on non-
orous alkylated poly(styrene-divinylbenzene) particles combines
ery high-resolution separation of nucleic acids under both non-
enaturing and denaturing conditions with very short analysis
imes, therefore offering signiﬁcant advantages and opportuni-
ies for the analysis of RNA compared to gel electrophoresis [29].
n addition, the advantages of chromatographic methods for the
uriﬁcation of siRNA and dsRNA has also been demonstrated
sing anion exchange chromatography using convective interac-
ion media monolithic columns [30].
To validate the presence of dsRNA, the RNA expressed in E. coli
as analysed using IP RP HPLC under non-denaturing conditions at
0 ◦C. The analysis of dsRNA and ssRNA generated from the same
emplate DNA using in vitro transcription is shown in Fig. 4a–d.
he results show that only a small change in the retention time is
bserved for the ssRNAs analysed at 50 ◦C and 75 ◦C. In contrast, a
arge change in the retention time is observed for duplex RNA when
omparing the IP RP HPLC analysis at 75 ◦C and 50 ◦C. Analysis of
he dsRNA at 75 ◦C effectively denatures the duplex dsRNA into
he corresponding two ssRNAs, which elute at the expected earlier
etention time compared to the dsRNA. Therefore, analysis of the
uplex dsRNA at 50 ◦C provides a rapid quantitative measurement
f the relative amount of duplex dsRNA generated. Further anal-
sis at 75 ◦C demonstrates the dissociation of the dsRNA strands,
roviding additional validation of the duplex nature of the dsRNA.
urther examination in this case reveals only a small amount of
sRNA is present from the in vitro transcription (see Fig. 4a–d). The
elative differences in the hydrophobicity of the duplex and ssRNA
pecies results in the different retention times using IP RP HPLC
onsistent with previous observations ([25], Noll et al., 2011).
It is interesting to note that often during in vitro transcription
eactions using high yield T7 polymerases IP RP HPLC analysis
evealed an excess of ssRNA compared to dsRNA (see Fig. 4e).
elative quantiﬁcation of the dsRNA was calculated from the IP
P HPLC by ﬁrst determining the relative peak areas of the same
sRNA (500 ng) analysed at both 50 ◦C and 75 ◦C. By measuring the
eak areas of the dsRNA and ssRNAs, this enables us to accurately
ccount for the hypochromicity of the dsRNA (see Supplementary
ig. S1a). Validation of the accuracy of the IP RP HPLC quantiﬁca-
ion was subsequently performed by mixing known amounts of theogr. A 1484 (2017) 14–25 21
ssRNA and dsRNA standards generated using in vitro transcription.
The standards were analysed using IP RP HPLC, peak areas mea-
sured and the correction factor determined above was applied to
determine the relative% of dsRNA. The results show good agree-
ment with calculated ratios of 51.9% and 68.9% compared with
expected ratios of 50% and 66.67% respectively (see Supplemen-
tary Fig. S1 b/c). From the chromatogram shown in Fig. 4e using the
method described, it was determined that 39.6% of the RNA gener-
ated from in vitro transcription was  dsRNA. These results highlight
the importance of analysing the relative proportion of ssRNA and
dsRNA using this approach prior to downstream applications of the
dsRNA. The in vitro transcribed material in which an excess of ssRNA
was present was further subjected to RNase T1 prior to analysis
using IP RP HPLC (See Fig. 4f). The results further verify the abil-
ity to completely remove the contaminating ssRNA in conjunction
with IP RP HPLC analysis to rapidly separate the duplex dsRNA from
its corresponding ssRNAs. The results demonstrate that IP RP HPLC
can rapidly analyse the dsRNA product, determine the purity of
the product and importantly gives information on the proportions
of ssRNA and dsRNA present. Furthermore, the application of IP RP
HPLC could also be extended to further purify the dsRNA if required
from contaminating salts, NTPs, ssRNA/dsRNA, and proteins.
To further validate the duplex nature of the puriﬁed dsRNA,
the temperature-dependent dissociation between the two  RNA-
strands was measured using both IP RP HPLC and the binding of
the duplex-intercalating ﬂuorophore SYBR green (see supplemen-
tary Fig. S2-4). The results conﬁrm the duplex nature of the puriﬁed
dsRNA where typical dissociation characteristics were observed
using both IP RP HPLC and SYBR green ﬂuorescence intensity mea-
surements. In contrast, as expected no temperature-dependent
dissociation was observed for ssRNA (see supplementary Fig. S2-4).
3.4. Characterisation of dsRNA using RNase mass mapping
Mass spectrometry has emerged as an increasingly power-
ful tool for the identiﬁcation and characterisation of nucleic
acids. Prior to mass spectrometry analysis, the RNA of interest
is routinely ﬁrst puriﬁed using HPLC [31–35]. This often large
biomolecule is subsequently digested with endonucleases into
smaller oligoribonucleotides that are more amenable for chro-
matographic separation and intact mass measurements [36,37].
Additional sequence information from the oligoribonucleotides can
be obtained using tandem mass spectrometry (MS/MS) via colli-
sion induced dissociation (CID) or post source decay (PSD) [38].
This approach has been successfully employed to characterise a
wide range of RNAs [31,37,39–42]. Ribonuclease (RNase) mapping
of dsRNA is limited by the availability of known dsRNA base speciﬁc
RNases. Whilst RNase A has previously been shown to cleave dsRNA
under speciﬁc ionic strength conditions, there is limited informa-
tion regarding the speciﬁcity under these conditions. Moreover,
RNase T1 is not active against dsRNA [28,43].
Here we  have optimised the analysis of dsRNA using RNase
digestion prior to liquid chromatography interfaced with mass
spectrometry analysis. To our knowledge, RNase mass mapping
approaches have only previously been employed to analyse ssRNA.
Expression of a 765 bp dsRNA in E. coli and puriﬁcation was  per-
formed as outlined previously. Subsequently the puriﬁed dsRNA
was digested with RNase A under optimised conditions and the
resulting oligoribonucletides were analysed using LC ESI MS  in
an approach to further characterise the dsRNA. Following LC ESI
MS analysis (see Fig. 5a) the identiﬁed oligoribonucleotides result-
ing from the monoisotopic masses obtained were compared to
the theoretical monoisotopic masses expected from an in silico
RNase A digest of the dsRNA. Analysis of the RNase mass mapping
data shows for the ﬁrst time that RNase A digestion speciﬁcally
digests the dsRNA 3′ of U and C residues (similar to its speci-
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Sense strand 
GGGAGCAAAAAACCCCGC GAGACCCCCGAAGAGGC CCCGCGGGGUUAAUGGCCC
UGCGACUACUCAACAGUGCUGGCUCCGCCAGCUGGCCUCUCAGCUGCCCAAGAG
UGCCCAGGUGGGCAGCGUGGCCGCCGUCCACACACUGGACAAGAUCGGCAAGC G
GGAGAUCGUUGGCUACGGCU GGAACGGCACCGCCUGCUACGCGGAUCGCGUGG
ACUACCCUCUGCCCGCCGUGCGCUUCCGUGAGC CCACCAACGAGAUCAACGCUCU
GCGCGCC AAGGAGCAGGGAGACUGGAAGAAGC UCAGCACCCAGGAGAU CAAGG
CCCUGUACCGCGCCAGCUUCUGCC AGACUAUCGCCGAGGUCCAGGC UGGAAGC G
GGGAGUGGAAGCUCCACCU GGGCGUUUCACUCCUCUUCUGCGCCGCCGCCAUCU
GGGUGGCCGUACUGAU GAACAUCUUCGUGUACGAUGAGC UGCCCGUUACCUUC
GAUGAGGAGCACCAGAAGGCGCAGCUGCAGCGCAUCAUCGACCUGGAAAUCAAC
CCCGUCACCGGAUUGACCUCCAAGUGGGACUACGAGAACAAGAAGUGGAAGAA
CCU GGAAUUGCUCAUGGUGGAGCUUCAGUUCCGCAAGGGCAUGAACGAUCUGC
UGGGUAAAACCCCGC GGGGCCUCUUC GGGGGU CUCGCGGGGU UUUUU
An-Sense strand 
GGGAGCAAAAAACCCCGCGAGACCCCCGAAGAGGCCCCGCGGGGUUUUACCCAG
CAGAUCGUUCAUGCCCUUGC GGAACUGAAGCUCCA CCAUGAGCAAUUCCAGGU
UCUUCCACUUCUUGUUCUCGUAGUCCCACUU GGAGGUCAAUC CGGUGAC GGGG
UUGAUUUCCAGGUCGAUGAU GCGCUGCAGCUGCGCCUUCUGGUGCUCCUCAUC
GAAGGUAAC GGGCAGCUCAUCGUACACGAAGAUGUUCAUCAGUACGGCCACCC A
GAUGGCGGCGGCGCAGAAGAGGAGUGAAAC GCCCAGGUGGAGCUUCCACUCCC
CGCUUCCAGCCU GGACCUCGGCGAUAGUCUGGCAGAAGC UGGCGCGGUACAGG
GCCUUGAUCUCCUGGGUGCUGAGCUUCUUCCAGUCUCCCUGCUCCUU GGCGCGC
AGAGCGUUGAUCUCGUUGGUGGGCUCAC GGAAGC GCACGGCGGGCAGAGGGU A
GUCCACGCGAUCCGCGUAGC AGGCGGUGC CGUUCCAGCCGUAG CCAACGAUCUC
CCGCUUGCCGAUCUUGUCCAGUGUGU GGACGGCGGCCACGCUGCCCACCU GGGC
ACUCUUGGGCAGCU GAGAGGCCAGCUGGC GGAGCACAGCACUGUUGAGUAGUC
GCAGGGCCAUUAACCCCGC GGGGCCUCUUC GGGGGUCUCGC GGGGUUUUUU
Fig. 5. RNase A Mass Mapping of the dsRNA using LC ESI MS.  (a) Base peak chromatogram of the oligoribonucleotides generated from an RNase A digest of the puriﬁed dsRNA.
Analysis was  performed using LC ESI MS  on a maXis ultra-high resolution time of ﬂight instrument. A number of the identiﬁed oligoribonucleotides are highlighted. (b)
Summary of the RNase mass mapping. Underlined bold = monoisotopic masses correspond to a number of theoretical sequence isomers in either sense or antisense strand.
Bold  = monoisotopic masses corresponding to a number of theoretical sequence isomers that are unique in either sense or antisense strand. Grey highlight = monoisotopic
masses corresponding to single predicted unique oligoribonucleotide sequence in only the sense or antisense strand.
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Fig. 6. RNase T1 Mass Mapping of the dsRNA using LC ESI MS.  (a) Base peak chromatogram of the oligoribonucleotides generated from an RNase T1 digest of the puriﬁed
dsRNA. Analysis was  performed using LC ESI MS on a maXis ultra-high resolution time of ﬂight instrument. A number of the identiﬁed oligoribonucleotides are highlighted.
(b)  Summary of the combined RNase A/T1 mass mapping. RNase A fragments are shown in red lines and RNase T1 in blue. Sequences highlighted in green = monoisotopic
masses  corresponding to a number of theoretical sequence isomers in either sense or antisense strand. Blue = monoisotopic masses corresponding to single predicted
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city in ssRNA). A map  of all the identiﬁed oligoribonucleotides
or both the sense and antisense strands of the dsRNA is sum-
arised in Fig. 5b and supplementary Fig. S5. For clarity the
dentiﬁed short oligoribonucleotides ≤3 mers are not included. Due
o the complexity of the sample, a number of oligoribonucleotidese T1 digest. Red = monoisotopic masses corresponding to single predicted unique
st. (For interpretation of the references to colour in this ﬁgure legend, the reader is
monoisotopic masses obtained could be assigned to a number of
different oligoribonucleotide sequences generated from the RNase
digest in either the sense or antisense strands. However a number
of monoisotopic masses were identiﬁed that correspond to unique
oligoribonucleotides including the oligoriobonucleotides AAGAUp
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1656.263 Da) and GAAGGUp (2017.320 Da) in the sense and anti-
ense strands respectively. The corresponding MS  and tandem MS
ata is shown in supplementary Fig. S6/7 providing further veriﬁca-
ion of the unique oligoribonucleotides in the sense and antisense
trands of the dsRNA. The RNase mass mapping identiﬁed all of
he theoretical RNase A oligoribonucleotides (≥4 mers) generated
rom the 765 bp dsRNA. The RNase A mass mapping of the dsRNA
n conjunction with the tandem MS  analysis of a number of unique
ligoriobonucleotides provides further evidence for the identiﬁca-
ion of the corresponding dsRNA sequence.
In an approach to improve the sequence coverage of dsRNA
sing RNase mass mapping, we developed a protocol for RNase
1 mass mapping of dsRNA. Although dsRNA is resistant to RNase
1 [28] it was proposed that following denaturation of the dsRNA
nto ssRNA under conditions that retained RNase T1 activity this
pproach would enable base speciﬁc cleavage of the dsRNA. A range
f denaturing reagents including urea and guanadinium hydrochlo-
ide were used in conjunction with RNase T1 without success (data
ot shown). In contrast, the addition of RNase T1 following the heat-
ng of dsRNA in the presence of DMSO resulted in efﬁcient cleavage
f the dsRNA (see Fig. 6a). Control experiments in the absence of
Nase T1 demonstrate that under these conditions the dsRNA is
ffectively denatured to ssRNA (see Fig. 6a). Following optimisa-
ion of the above method RNase T1 digest of the 765 bp dsRNA was
erformed using LC ESI MS  analysis (see Fig. 6b). Following LC ESI
S analysis the identiﬁed oligoribonucletides resulting from the
onoisotopic masses obtained were compared to the theoretical
onoisotopic masses expected from an in silico RNase T1 digest of
he dsRNA. Analysis of the RNase mass mapping data shows that
Nase T1 digestion speciﬁcally digests the dsRNA 3′ side of G. A
ap  of all the identiﬁed oligoribonucleotides for both the sense
nd antisense strands of the dsRNA is shown in supplementary Fig.
8. For clarity the identiﬁed short oligoribonucleotides ≤3 mers are
ot included. Following RNase mass mapping of the dsRNA using
oth RNase A/T1 the combined RNase mass map  is shown in Fig. 6c.
sing this combined approach over 82% and 77% sequence coverage
as obtained based on the identiﬁcation of oligoribonucleotides
>3mers) for the sense and antisense strands respectively.
. Conclusions
We  have developed a range of analytical tools that enable the
igh throughput puriﬁcation and characterisation of dsRNA. In
his study we have optimised standard, commercially available
RIzol extractions in conjunction with a single step protocol to
emove contaminating DNA and ssRNA during the puriﬁcation pro-
edure. In addition, we have utilised and developed IP RP HPLC
or the rapid, high resolution analysis of the dsRNA. This approach
nables accurate sizing of the dsRNA, and further veriﬁcation of
he purity of the duplex dsRNA product over contaminating rRNAs
nd corresponding ssRNAs. These combined approaches enable
he high throughput puriﬁcation and analysis of a wide range
f dsRNAs generated either via bacterial expression systems or
n vitro transcription. In addition, we have developed and optimised
Nase mass mapping approaches using RNase A and novel meth-
ds in conjunction with RNase T1 to further characterise dsRNA
n conjunction with liquid chromatography interfaced with mass
pectrometry analysis. The application of robust analytical meth-
ds to rapidly assess product quality following the puriﬁcation of
he dsRNA product from impurities including contaminating RNAs
ombined with methods to characterise and identify the dsRNA
roducts are important requirements prior to the downstream
pplication of dsRNA for RNAi studies. The development of RNase
ass mapping approaches to characterise dsRNA is also hugely
mportant to RNAi applications as dsRNA is not readily amenable
[
[ogr. A 1484 (2017) 14–25
to conventional or next-generational sequencing techniques (NGS).
NGS approaches generate only short reads therefore does not read-
ily provide important quantitative characterisation of large dsRNA.
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